ABVC BioPharma, Inc. Professional Fees
ABVC BioPharma, Inc. (ABVC) reported Professional Fees of $383.50 thousand for the 1-month period ending 2023-11-30, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-03-03
- ABVC BioPharma, Inc. professional fees for the quarter ending 2022-06-30 was $0.00.
- ABVC BioPharma, Inc. professional fees for the quarter ending 2022-03-31 was $4.51M.
- ABVC BioPharma, Inc. professional fees for the quarter ending 2012-06-30 was $19.16K, a 61.24% decline year-over-year.
- ABVC BioPharma, Inc. professional fees for the quarter ending 2012-03-31 was -$14.77K, a 112.61% decline year-over-year.
- ABVC BioPharma, Inc. professional fees for fiscal 2021 was $4.51M.
- ABVC BioPharma, Inc. professional fees for fiscal 2011 was $217.80K, a 49.83% decline from fiscal 2010.
- ABVC BioPharma, Inc. professional fees for fiscal 2010 was $434.12K.
| Period end | Professional Fees | Professional Fees 1 month | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|---|---|
| 2023-11-30 | $383.50K 10-Q/A · filed 2026-03-03 | $383.50K 10-K · filed 2026-03-03 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | $4.51M 10-Q · filed 2022-11-14 | ||||
| 2022-03-31 | $4.51M 10-Q · filed 2022-05-16 | |||||
| 2021-12-31 | $4.51M 10-K · filed 2022-03-31 | |||||
| 2019-12-31 | $4.51M 10-Q · filed 2021-11-15 | |||||
| 2012-06-30 | $19.16K 10-Q/A · filed 2012-08-20 | $4.40K derived: sum of 2 quarters · filed 2012-08-20 | $98.04K 10-Q/A · filed 2012-08-20 | $123.38K derived: sum of 4 quarters · filed 2012-08-20 | ||
| 2012-03-31 | -$14.77K 10-Q · filed 2012-05-15 | $78.88K 10-Q · filed 2012-05-15 | $104.21K derived: sum of 3 quarters · filed 2012-05-15 | $153.65K derived: sum of 4 quarters · filed 2012-08-20 | ||
| 2011-12-31 | $93.64K 10-Q · filed 2012-02-21 | $118.98K derived: sum of 2 quarters · filed 2012-02-21 | $168.42K derived: sum of 3 quarters · filed 2012-08-20 | $285.47K derived: sum of 4 quarters · filed 2012-08-20 | ||
| 2011-09-30 | $25.34K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2011-12-28 | $74.78K derived: sum of 2 quarters · filed 2012-08-20 | $191.83K derived: sum of 3 quarters · filed 2012-08-20 | $217.80K 10-K/A · filed 2011-12-28 | ||
| 2011-06-30 | $49.44K 10-Q/A · filed 2012-08-20 | $166.49K derived: sum of 2 quarters · filed 2012-08-20 | $192.46K 10-Q/A · filed 2012-08-20 | $274.80K derived: sum of 4 quarters · filed 2012-08-20 | ||
| 2011-03-31 | $117.06K 10-Q · filed 2012-05-15 | $147.22K 10-Q · filed 2012-05-15 | $225.36K derived: sum of 3 quarters · filed 2012-05-15 | $309.56K derived: sum of 4 quarters · filed 2012-05-15 | ||
| 2010-12-31 | $30.17K 10-Q · filed 2012-02-21 | $108.30K derived: sum of 2 quarters · filed 2012-02-21 | $192.51K derived: sum of 3 quarters · filed 2012-02-21 | |||
| 2010-09-30 | $78.14K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2011-12-28 | $162.34K derived: sum of 2 quarters · filed 2011-12-28 | $434.12K 10-K/A · filed 2011-12-28 | |||
| 2010-06-30 | $84.20K 10-Q/A · filed 2011-09-08 | $355.99K 10-Q/A · filed 2011-09-08 |